Royal Liverpool and Broadgreen University Hospitals NHS Trust

The Royal Liverpool and Broadgreen University Hospitals NHS Trust incorporates Royal Liverpool University Hospital and Broadgreen Hospital http://www.rlbuht.nhs.uk/

Prior to 2022, outcomes were separately reported for Aintree and Royal Liverpool Hospital

View latest outcomes

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site MRI liver facilities
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Oncology services:
    • On-site chemotherapy services
  • Advanced disease services:
    • Dedicated Specialist Advanced MDT
  • Support service facilities:
    • Dedicated nurses for ERAS services

Data Quality

All Patients: Trust Network National
Number of patients in Audit 198 1506 29766
Case ascertainment (%) 91 97 90
Data completeness of:
– Pre-treatment TNM (%) 74 94 83
– Performance status (%) 2 84 85
Patients having major resection: Trust Network National
Number of patients in Audit 127 891 16499
ASA grade 1 (%) 3 10 10
ASA grade 2 (%) 76 60 53
ASA grade 3 (%) 20 28 30
ASA grade 4+ (%) 1 2 3
ASA grade not recorded (%) 1 1 4
Data completeness of:
7 Audit items for risk-adjustment (%) 95 87 86

Key:

> 80%
50 - 80%
< 50%

Management of all patients

All Patients: Trust Network National
Number of patients in Audit 198 1506 29766
Seen by Clinical Nurse Specialist (%) 80 86 86
All patients deemed potentially curative Trust Network National
Number of potentially curative patients 50 387 7226
Undergoing major resection (%) 90 84 86

Management of patients having major resection

Patients having major resection: Trust Network National
Number of patients in Audit 127 891 16474
Distant metastases (%) 2 4 6
Urgent or emergency surgery (%) 9 14 15
At least 12 lymph nodes excised (%) 92 83 84
Laparoscopic surgery attempted (%) 70 66 72
Risk-adjusted length of stay > 5 days (%) 63 67 62
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 80 505 10641
Adjuvant chemotherapy (%) 61 55 61

Rectal cancer patients

Patients having major resection: Trust Network National
Number of patients in Audit 37 211 3899
Neoadjuvant therapy (%) 46 42 32
Circumferential resection margin: Recorded (%) 68 80 86
Circumferential resection margin: Negative (%) 19 63 79
Rectal volume N/A N/A N/A
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate N/A N/A N/A
APER/Hartmanns (%) N/A N/A N/A

Compare trust outcomes